Sign in

CIK 0001806952

  • Non-accelerated filer
  • Smaller reporting company

Lyell Immunopharma, Inc.

Sign in to watch
Ticker
LYEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
833006753
Phone
+1 650-695-0677
Business address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Planned sale 10% owner sold 10 shares at $13.73 ($137)
  2. 4 Other disposition 10% owner disposed of 76,000 shares (other)
  3. 4 Other disposition 10% owner disposed of 66,500 shares (other)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market sale President and CEO sold 388 shares at $18.91 ($7,337)
  6. 4 Open-market sale Chief Scientific Officer sold 130 shares at $18.92 ($2,460)
  7. 4 Open-market sale Chief Operating Officer sold 89 shares at $18.92 ($1,684)
  8. 4 Open-market sale VP, Corporate Controller sold 217 shares at $18.91 ($4,103)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale Chief Medical Officer sold 1,977 shares at $12.64 ($24,989)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market buy 10% owner bought 488,090 shares at $25.61 ($12,499,985)
  20. 4 Open-market buy 10% owner bought 488,090 shares at $25.61 ($12,499,985)

Page 2 of 9 · 173 filings